Skip to main content
Clinical Trials/NCT01626417
NCT01626417
Completed
N/A

A Prospective, Experimental Study to Evaluate Transfer Kinematics and Kinetics of Chronic Post-stroke Patients With Tibion Bionic Leg

Tibion Bionics, Inc.2 sites in 1 country20 target enrollmentMay 2012
ConditionsStroke

Overview

Phase
N/A
Intervention
Not specified
Conditions
Stroke
Sponsor
Tibion Bionics, Inc.
Enrollment
20
Locations
2
Primary Endpoint
Force
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The objective of this clinical study is to examine the acute kinematics and kinetics of utilizing the Tibion Bionic Leg in a sample of chronic post-stroke patients performing sit-to-stand and stand-to-sit transfers across a range of assistance and resistance settings (internal to the device); to compare these metrics to baseline performance without the Bionic Leg; and to determine the Bionic Leg settings that optimize a restorative (equal force distribution) movement state in these patients.

Detailed Description

Comprehensive motion (kinetics and kinematics) data specific to sit-to-stand and stand-to-sit transfers with and without the Tibion Bionic Leg. The Vicon Motion Analysis System will be utilized to track movement using markers on the subject and the Bionic Leg per the UCSF Human Performance Center's routine. Once outfitted with the marker system, patients will be instructed to perform multiple sit-to-stand and stand-to-sit transfers while data is gathered. The sit-to-stand and stand-to-sit transfers will be performed using a standard chair, with a seat height not less than 12" from the floor. The chair will be positioned such that, at sitting rest, each of the subject's feet are positioned on limb-specific force plates (left and right).

Registry
clinicaltrials.gov
Start Date
May 2012
End Date
November 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Tibion Bionics, Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Single ischemic stroke with residual unilateral lower-extremity weakness
  • Chronic post-stroke (\>12 months since event)
  • Eligible to participate to lower extremity physical therapy
  • Age 30 years or greater
  • Able to ambulate at least 10 meters without therapist assistance
  • Able to ambulate without a leg brace
  • Able to transfer from sitting to standing without physical assistance from a therapist
  • Able to transfer from standing to sitting without physical assistance from a therapist
  • Subject must understand the nature of the study and provide written informed consent prior to enrollment.
  • Subject must be willing and able to attend all study sessions

Exclusion Criteria

  • Medically unstable
  • Age younger than 30 years
  • Subacute post-stroke (\< 12 months since event)
  • Status-post multiple strokes
  • Status-post traumatic brain injury
  • Not eligible to participate in lower extremity physical therapy
  • Concomitant degenerative neurological conditions
  • Not able to ambulate at least 10 meters without therapist assistance
  • Unable to ambulate without a leg brace
  • Unable to transfer from sitting to standing without physical assistance from a therapist

Outcomes

Primary Outcomes

Force

Time Frame: Subject participation in the study is up to one (1) week.

Force, in Newtons (N), by limb, as measured by kinematic and kinetic analysis during sit-to-stand and stand-to-sit transfers with and without the Tibion Bionic Leg.

Secondary Outcomes

  • Torque(Subject participation is up to one (1) week)
  • Work(Subject participation in study is up to one (1) week.)
  • Moment(Subject participation is up to one (1) week)

Study Sites (2)

Loading locations...

Similar Trials